Sun Pharmaceutical

News across the web »
Interact & exchange stock tips & market info »

Web Messenger

Platinum Member

107814 Followers

Web Messenger

Platinum Member

107814 Followers

MMB Messenger

Platinum Member

112422 Followers

Related News »
Mumbai, May 18, 2012: Sun Pharmaceutical Industries Ltd. (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715) announced that the USFDA has granted its subsidiary an approval for its Abbreviated New Drug Application (ANDA ...
May 18, 2012 at 11:54 | Source: Phramalive.com
Mumbai, May 24, 2012: Sun Pharmaceutical Industries Ltd. (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715) announced that the USFDA has granted its subsidiary an approval for its Abbreviated New Drug Application (ANDA ...
May 24, 2012 at 11:40 | Source: Phramalive.com
Mumbai: Drug maker Sun Pharmaceutical Industries Ltd’s Israeli subsidiary Taro Pharmaceutical Industries Ltd almost doubled its net profit to $47.3 million in the January-March quarter. The company had posted a net profit of $25.7 million in the year-ago period.
May 25, 2012 at 09:16 | Source: Livemint.com
New Delhi: Sun Pharmaceutical Industries today said it has received approval from the US health regulator to sell its generic version of Astelin, used in treating nasal allergies, in the American market. The company has received approval from ...
May 25, 2012 at 04:51 | Source: zeenews.india.com
(RTTNews) - Taro Pharmaceutical Industries Ltd. (TARO: News ) Thursday reported an increase in profit for the first quarter, as revenue surged and margins improved. Net income attributable to Taro improved to $47.3 million or $1.06 per share, compared to $ ...
May 24, 2012 at 22:17 | Source: RTT News
Maryland has hosted 1,775 clinical trials for new medicines targeting six major chronic diseases since 1999, including 369 that are still in the early stages of recruiting patients, according to a study by two pharmaceutical industry groups ...
May 18, 2012 at 23:14 | Source: Baltimore Sun
Pharmaceutical companies, which were spared some of the more sweeping regulations in President Barack Obama's healthcare overhaul, could come under more pressure if the U.S. Supreme Court strikes down part or all of the 2010 law. Drugmakers agreed to pay ...
May 27, 2012 at 09:49 | Source: Edmonton Sun
Special Committee of the Board of Directors of Taro Pharmaceutical Industries Ltd. Evaluating Sun Acquisition Proposal Euro Park (Italy Building) Yakum Business Park, Yakum 60972, Israel Attention: Professor Dov Pekelman, Chairman of the Special Committee ...
May 9, 2012 at 23:53 | Source: PR-USA.net
NORWICH – One month after returning from an eye-opening trip to the Philippines, Norwich Pharmaceutical Department Manager Bridgetta Jones will speak of the experience at a special brunch and fundraiser, to be held at 9 a.m. Saturday at the ...
May 18, 2012 at 13:06 | Source: Evening Sun
Uday Baldota, a spokesman for Sun Pharmaceutical Industries, an Indian drug maker that has received tentative approval to sell generic Plavix, said his company often planned for the introduction of a new drug seven to eight years ahead of time ...
May 16, 2012 at 20:32 | Source: New York Times